Deferiprone in iron overload.
作者信息
Hoffbrand A V, Wonke B
出版信息
N Engl J Med. 1995 Aug 31;333(9):598-9.
PMID:7623918
Abstract
摘要
相似文献
1
Deferiprone in iron overload.
N Engl J Med. 1995 Aug 31;333(9):598-9.
2
Deferiprone in iron overload.去铁酮治疗铁过载
N Engl J Med. 1995 Aug 31;333(9):598.
3
Oral iron chelation.口服铁螯合疗法。
Semin Hematol. 1996 Jan;33(1):1-8.
4
Arthropathy in thalassaemia patients receiving deferiprone.接受去铁酮治疗的地中海贫血患者的关节病
Lancet. 1994 Jul 23;344(8917):262-3. doi: 10.1016/s0140-6736(94)93029-5.
5
Agranulocytosis due to deferiprone: a case report with cytomorphological and functional bone marrow examination.去铁酮所致粒细胞缺乏症：一例伴有骨髓细胞形态学和功能检查的病例报告
Blood Transfus. 2011 Oct;9(4):462-5. doi: 10.2450/2011.0098-10. Epub 2011 Jul 18.
6
Agranulocytosis and thrombocytopenia in patient with Blackfan-Diamond anaemia during oral chelator trial.
Lancet. 1989 Aug 19;2(8660):457. doi: 10.1016/s0140-6736(89)90641-7.
7
Agranulocytosis and thrombocytopenia, Blackfan-Diamond anaemia, and oral chelation.
Lancet. 1990 Apr 21;335(8695):970. doi: 10.1016/0140-6736(90)91031-5.
8
Safety profile of the oral iron chelator deferiprone: a multicentre study.口服铁螯合剂去铁酮的安全性概况：一项多中心研究。
Br J Haematol. 2000 Feb;108(2):305-12. doi: 10.1046/j.1365-2141.2000.01866.x.
9
Deferiprone-associated myelotoxicity.去铁酮相关的骨髓毒性。
Eur J Haematol. 1994 Nov;53(5):298-301. doi: 10.1111/j.1600-0609.1994.tb01323.x.
10
Deferiprone: New insight.去铁酮：新见解。
Ann N Y Acad Sci. 2005;1054:169-74. doi: 10.1196/annals.1345.019.
Zotero 插件